Loading
A phase 2 trial of High-dose intravenous vitamin C in Rectal cancer, run by Sixth Affiliated Hospital, Sun Yat-sen University, not yet recruiting.
NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC is a phase 2 interventional study registered as NCT07765667 by Sixth Affiliated Hospital, Sun Yat-sen University, with 100 participants planned, started 2026-09-01 and due to reach its primary completion in 2029-09-01. Interventions recorded: Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen, Ketogenic Diet, Surgical resection, Vitamin C. Conditions recorded: Rectal Adenocarcinoma, High-Risk Cancer, MSS.
Linked to the technology High-dose intravenous vitamin C because the registry's title names it ("high dose intravenous vitamin c") and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.
Shares High-dose intravenous vitamin C, Rectal cancer and the tag pipeline.
Shares High-dose intravenous vitamin C and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin) and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.